Bellevue Group AG Q3 2016 Filing
Filed November 10, 2016
Portfolio Value
$553.5B
Holdings
121
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (121 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —Team Health Holdings Inc. | 25,000 | $814.0M | 0.15% | |
| 102 | —GW Pharmaceuticals PLC | 6,000 | $796.0M | 0.14% | |
| 103 | —AAC Hldgs Inc | 45,000 | $783.0M | 0.14% | |
| 104 | NVROEURNevro Corp. | 7,500 | $783.0M | 0.14% | |
| 105 | —Kite Pharma, Inc. | 14,000 | $782.0M | 0.14% | |
| 106 | EX9Exelixis, Inc. | 60,000 | $767.0M | 0.14% | |
| 107 | UTHUnited Therapeutics Corporation | 6,300 | $744.0M | 0.13% | |
| 108 | VAREURVarian Medical Systems, Inc. | 7,000 | $697.0M | 0.13% | |
| 109 | NVAXNovavax, Inc. | 325,000 | $676.0M | 0.12% | |
| 110 | TBPHTheravance Biopharma, Inc. | 18,428 | $668.0M | 0.12% | |
| 111 | DVADavita Healthcare Partners, Inc. | 10,000 | $661.0M | 0.12% | |
| 112 | —Celldex Therapeutics, Inc. | 160,000 | $646.0M | 0.12% | |
| 113 | PODDInsulet Corporation | 15,000 | $614.0M | 0.11% | |
| 114 | ESPREsperion Therapeutics Inc. | 40,000 | $554.0M | 0.10% | |
| 115 | RMEResMed Inc. | 8,000 | $518.0M | 0.09% | |
| 116 | PENPenumbra, Inc. | 5,000 | $380.0M | 0.07% | |
| 117 | —Webmd Health Corp | 7,400 | $368.0M | 0.07% | |
| 118 | SGRYSurgery Partners, Inc. | 15,000 | $304.0M | 0.05% | |
| 119 | MYGNMyriad Genetics, Inc. | 14,000 | $288.0M | 0.05% | |
| 120 | —Quorum Health Corp | 12,500 | $78.0M | 0.01% | |
| 121 | CLDNEUREiger BioPharmaceuticals, Inc. | 3,333 | $45.0M | 0.01% |
PreviousPage 2 of 2